YD Bio Insider Trades
NASDAQ: YDESHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 3 · $128.53K
- Sales
- 0 · $0
- Shares bought / sold
- 34.18K / 0
- Net activity
- Net buying $128,525
YD Bio insider activity
Over the last 12 months, YD Bio insiders reported 9 transactions on SEC Form 4: 3 open-market purchases and 0 sales. Insiders bought $128,525 and sold $0 worth of stock, for net insider buying of $128,525. The most recent filing shows Chang Kochi (Director) reporting a transaction in 3,135 shares on Sep 30, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put YDES's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
YDES insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | Lu Shao-TaDirector | Option exercise | 3,135 | — | Form 4 |
| Sep 30, 2026 | Chang KochiDirector | Option exercise | 3,135 | — | Form 4 |
| Sep 14, 2026 | Shen Ethan PhDCEO | Buy | 12,700 | $48.90K | Form 4 |
| Sep 9, 2026 | Shen Ethan PhDCEO | Buy | 3,100 | $12.18K | Form 4 |
| Sep 4, 2026 | Shen Ethan PhDCEO | Buy | 18,378 | $67.45K | Form 4 |
| Jun 30, 2026 | Chang KochiDirector | Option exercise | 5,749 | — | Form 4 |
| Jun 30, 2026 | Lu Shao-TaDirector | Option exercise | 5,749 | — | Form 4 |
| Mar 31, 2026 | Chang KochiDirector | Option exercise | 2,081 | — | Form 4 |
| Mar 31, 2026 | Lu Shao-TaDirector | Option exercise | 2,081 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4